KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

News
April 10, 2026
KHA's Jim Musser discussed the significant role hospitals play in supporting job creation during a meeting with the Morehead-Rowan County Chamber of Commerce.
News
April 2, 2026
On March 31, the Kentucky Statewide Opioid Stewardship (KYSOS) program hosted its first Opioid Summit.
Awards News
March 26, 2026
During this week’s 2026 KHA Quality Conference, attendees from multiple hospitals provided live, digital poster presentations.